Prescribing Information
Download Prescribing Information

Health Professional Information

Dosage Forms and Strengths

3 DOSAGE FORMS AND STRENGTHS

For Epidural test dose, Lidocaine Hydrochloride and Epinephrine Injection, USP 1:200,000 is a clear, colorless to slightly yellow solution available as:

1.5% (75 mg/5 mL) (15 mg/mL), 5 mL single-dose ampuls

Lidocaine Hydrochloride and Epinephrine Injection, USP 1:200,000 is a clear, colorless to slightly yellow solution available as:

1.5% (450 mg/30 mL) (15 mg/mL), 30 mL single-dose vials
2% (400 mg/20 mL) (20 mg/mL), 20 mL single-dose vials

Lidocaine Hydrochloride and Epinephrine Injection 1:200,000, USP is a clear, colorless to slightly yellow solution available as:

0.5% (250 mg/mL) (5 mg/mL), 50 mL multiple-dose vials

Lidocaine Hydrochloride and Epinephrine Injection 1:100,000, USP is a clear, colorless to slightly yellow solution available as:

1% (200 mg/20 mL) (10 mg/mL), 20 mL multiple-dose vials
1% (300 mg/30 mL) (10 mg/mL), 30 mL multiple-dose vials
1% (500 mg/50 mL) (10 mg/mL), 50 mL multiple-dose vials
2% (400 mg/20 mL) (20 mg/mL), 20 mL multiple-dose vials
2% (600 mg/30 mL) (20 mg/mL), 30 mL multiple-dose vials
2% (1000 mg/50 mL) (20 mg/mL), 50 mL multiple-dose vials
Medication Guide
Download Consumer Medicine Information

Health Professional Information

{{section_name_patient}}

{{section_body_html_patient}}

Additional Resources

Chat online with Pfizer Medical Information regarding your inquiry on a Pfizer medicine or vaccine.

Speak with a Pfizer Medical Information Professional regarding your Pfizer medicine or vaccine inquiry.

Available 9AM-5PM ET Monday to Friday; excluding holidays.

 

Submit a medical question for a Pfizer medicine or a vaccine. 

The submission will be reviewed during our standard business hours.

To report an adverse event related to a Pfizer product and you are not part of a clinical trial* for this medication, click the link below to submit your information: 
Pfizer Safety Reporting Site

*If you are involved in a clinical trial for either product, adverse events should be reported to your coordinating study site.

If you cannot use the above website to report an adverse event related to a Pfizer medication, please call (800) 438-1985.

You may also contact the U.S. Food and Drug Administration (FDA) directly to report adverse events or product quality concerns either online at www.fda.gov/medwatch or by calling (800) 332-1088.